Amir Goldkorn

4PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.

Seth P Lerner, David J McConkey, Catherine M Tangen

|Mar 30, 2023
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial).

Michael J Morris, Glenn Heller, David W Hillman

|Oct 05, 2022
External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer.

Umang Swami, Nicolas Sayegh, Yeonjung Jo

|Apr 21, 2022
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).

Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain

Pageof 1

Frequent Collaborators

2 joint publications

Neeraj Agarwal

2 joint publications

Catherine M Tangen

1 joint publications

Maha H A Hussain

1 joint publications

Shilpa Gupta